Full Access

Magnesium concentration in plasma and erythrocytes in MS

Corresponding Author

Z. Stelmasiak

Department of Neurology, School of Medicine, Lublin, Poland

Zbigniew Stelmasiak, Scientific and Clinical Centre for Demyelinating Diseases, 20-718 Lublin, ALKrasnicka 100, PolandSearch for more papers by this author

J. Solski,

J. Solski

Department of Clinical Analytics, Research Group for Demyelinating Diseases, Lublin, Poland

Search for more papers by this author

B. Jakubowska,

B. Jakubowska

Department of Clinical Analytics, Research Group for Demyelinating Diseases, Lublin, Poland

Search for more papers by this author

Z. Stelmasiak,

Corresponding Author

Z. Stelmasiak

Department of Neurology, School of Medicine, Lublin, Poland

Zbigniew Stelmasiak, Scientific and Clinical Centre for Demyelinating Diseases, 20-718 Lublin, ALKrasnicka 100, PolandSearch for more papers by this author

J. Solski,

J. Solski

Department of Clinical Analytics, Research Group for Demyelinating Diseases, Lublin, Poland

Search for more papers by this author

B. Jakubowska,

B. Jakubowska

Department of Clinical Analytics, Research Group for Demyelinating Diseases, Lublin, Poland

Search for more papers by this author

First published: July 1995

https://doi.org/10.1111/j.1600-0404.1995.tb00476.x

Citations: 12

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

Abstract

There are few reports of Mg in MS and none dealing with Mg content in erythrocytes. Mg concentration was determined in serum and in erythrocytes with the help of a BIOTROL Magnesium Calmagite colorimetric method (average sensitivity: 0.194 A per mmol/I) and a Hitachi autoanalyzer in 24 MS patients (7 men and 17 women, age 29–60; 37 years on average with the duration of the disease: 3–19; 11 years on average, at clinical disability stages according to the Kurtzke scale: 1–7; 3.2 on average, in remission stage. A statistically significant decrease (p <0.001) of Mg concentration in erythrocytes and no changes in plasma of MS patients were found. The results obtained suggest the presence of changes in membrane of erythrocytes which could be connected with their shorter life and with affection of their function.

References

1 Abernethy MH, Fowler RT. Micellar improvement of the calmagite compleximetric measurement of magnesium in plasma. Clin Chem 1982: 28: 520–2.
CAS PubMed Web of Science® Google Scholar
2 Beattifora HA. Effects of magnesium deficiency on blood cells. Clinical and experimental data. In: J. Durlach 1st Internat Symp on magnesium deficit in human pathology. France : Vittel, 1971: 501–16.
Google Scholar
3 Bogden JD, Troiano RA, Joselow MM. Copper, zinc, magnesium and calcium in plasma and cerebrospinal fluid of patients with neurological diseases. Clin Chem 1977: 23: 485–94.
CAS PubMed Web of Science® Google Scholar
4 Darlu P, Rao DC, Henrotte JG, Lalouel JM. Genetic regulation of plasma and red blood cell Mg concentrations in man. I. Univariate and bivariate path analyses. Am J Hum Genet 1982: 34: 874–87.
CAS PubMed Web of Science® Google Scholar
5 Durlach J. Le magnesium en pratique clinique. Warsaw PZWL, 1991: 24–25.
Google Scholar
6 Fishman RA. Neurological aspects of magnesium metabolism. Arch Neurol 1965: 12: 562–69.
10.1001/archneur.1965.00460300010002
CAS PubMed Web of Science® Google Scholar
7 Ginsburg S, Smith JG, Ginsburg FM, Reardon JZ, Aikwa JK. Magnesium metabolism of human and rabbit erythrocytes. Blood 1962: 20: 722–9.
CAS PubMed Web of Science® Google Scholar
8 Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med-Hypotheses 1986: 21: 193–200.
10.1016/0306-9877(86)90010-1
CAS PubMed Web of Science® Google Scholar
9 Greiner AC, Chan SC, Nicolson GA. Human brain contents of calcium, copper, magnesium and zinc in some neurological pathologies. Clin Chim Acta 1975: 64: 211–13.
10.1016/0009-8981(75)90203-X
CAS PubMed Web of Science® Google Scholar
10 Gupta JK, Ingegno AP, Cook AW, Pertschuk LP. Multiple sclerosis and malabsorption. Am J Gastroenterol 1977: 68: 560–5.
CAS PubMed Web of Science® Google Scholar
11 Hahn N, Paschen K, Haller J. Das verhalten von Kupfer, Eisen, Magnesium, Calcium und Zink bei Frauen mit normalen Menstruationcycles unter einnahme von Ovulationen hemmern und in der Gravidat. Arch Gynaekol 1972: 213: 176–186.
10.1007/BF00667673
CAS PubMed Web of Science® Google Scholar
12 Kapaki E, Segditsa J, Papageorgiou C. zinc, copper and magnesium concentration in serum and CSF of patients with neurological disorders. Acta Neurol Scand 1989: 73: 373–78.
10.1111/j.1600-0404.1989.tb03803.x
Google Scholar
13 Kay JE. Interaction of lymphocytes and phytohaemagglutinin: inhibition by chelating agents. Exp. Cell Res 1971: 68: 11–16.
10.1016/0014-4827(71)90580-5
CAS PubMed Web of Science® Google Scholar
14 Khayam-Bashi H, Liu TZ, Walter V. Measurement of serum Mg with a centrifugal analyser. Clin Chem 1977: 23: 289–91.
CAS PubMed Web of Science® Google Scholar
15 Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (Cleveland) 1983: 33: 1444–52.
10.1212/WNL.33.11.1444
CAS PubMed Web of Science® Google Scholar
16 Link M, Tibbing G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Invest 1977: 37: 397–401.
Google Scholar
17 Palm R, Hallams G. Zinc and copper in multiple sclerosis. J Neurol Neurosurg Psych 1982: 45: 691–98.
10.1136/jnnp.45.8.691
CAS PubMed Web of Science® Google Scholar
18 Poser CM, Paty DW, Scheinberget Al. New diagnostic criteria for multiple sclerosis. Guidelines for research protocols. Ann Neurol 1983: 13: 227–231.
10.1002/ana.410130302
CAS PubMed Web of Science® Google Scholar
19 Rieder HP, Schoettli G, Seiler H. Trace elements in whole blood of multiple sclerosis. Eur Neurol 1983: 22: 8592.
10.1159/000115542
CAS Web of Science® Google Scholar
20 Solski J, Jakubowska B. Red blood cell sialic acids in healthy subjects. Correlation with the age distribution of erythrocytes as assayed by glutamic oxalacetic transaminase determination (GOT). ABC 1994: 4: 162–171.
Google Scholar
21 Takeoka T, Shinohara Y, Furumi K, Mori K. Impairment of blood-CSF barrier in multiple sclerosis. J Neurochem 1983: 41: 1102–08.
10.1111/j.1471-4159.1983.tb09058.x
CAS PubMed Web of Science® Google Scholar
22 Tourtellotte WW, Ma BI. Multiple sclerosis: the bloodbrain barrier and the measurement of de novo central nervous system IgG synthesis. Neurology 1978: 28: 76–83.
10.1212/WNL.28.9_Part_2.76
CAS PubMed Web of Science® Google Scholar
23 Yasui M, Yase Y, Ando M, Adachi K, Mukoyama M, Ohsugi K. Magnesium concentration in brains from multiple sclerosis patients. Acta Neurol Scand 1990: 81: 197–200.
10.1111/j.1600-0404.1990.tb00965.x
CAS PubMed Web of Science® Google Scholar

Magnesium concentration in plasma and erythrocytes in MS

Abstract

References

Citing Literature